Weekly Analysts’ Ratings Changes for Avantor (AVTR)

Avantor (NYSE: AVTR) recently received a number of ratings updates from brokerages and research firms:

• 6/27/2026 – Avantor was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/26/2026 – Avantor is now covered by Sanford C. Bernstein. They set a “market perform” rating and a $10.50 price target on the stock.
• 6/25/2026 – Avantor was upgraded by Sanford C. Bernstein to “hold”.
• 6/24/2026 – Avantor was given a new $8.00 price target by UBS Group AG.
• 6/24/2026 – Avantor had its price target raised by Barclays PLC from $7.00 to $8.00. They now have an “underweight” rating on the stock.
• 6/1/2026 – Avantor was downgraded by Wolfe Research to “underperform”. They now have a $7.00 price target on the stock.
• 6/1/2026 – Avantor was upgraded by Wolfe Research to “strong sell”.
• 5/30/2026 – Avantor was downgraded by Wall Street Zen from “buy” to “hold”.
• 5/14/2026 – Avantor is now covered by Royal Bank Of Canada. They set a “sector perform” rating and a $9.00 price target on the stock.
• 5/14/2026 – Avantor was upgraded by Royal Bank Of Canada to “hold”.
• 5/9/2026 – Avantor was upgraded by Wall Street Zen from “hold” to “buy”.

Insider Buying and Selling

In other news, Director Simon Dingemans acquired 25,000 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The shares were bought at an average price of $8.14 per share, with a total value of $203,500.00. Following the completion of the purchase, the director directly owned 25,000 shares in the company, valued at $203,500. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gregory T. Lucier acquired 10,000 shares of Avantor stock in a transaction on Friday, May 8th. The shares were purchased at an average price of $8.32 per share, for a total transaction of $83,200.00. Following the completion of the acquisition, the director directly owned 60,000 shares in the company, valued at $499,200. This trade represents a 20.00% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.28% of the stock is currently owned by insiders.

Get Avantor Inc alerts:

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.

Featured Stories

• Five stocks we like better than Avantor
• Burger King’s Turnaround Is Putting Restaurant Brands Back in Focus
• Short Squeeze Alert—Moderna Stock Surges on New Strategy
• NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
• Amazon Could Be About to Reap the Rewards of a Software Spending Boom

Receive News & Ratings for Avantor Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor Inc and related companies with MarketBeat.com's FREE daily email newsletter.